Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomas.
Martí Mascaró-PolRamón Díez-FeijooJuan Jose Rodriguez-SevillaConcepción Fernández-RodriguezFrancesc García-PallarolsSolange FloresIvonne VazquezSaray Rodriguez-LopezDavid RomanEva GimenoLuis ColomoJose MaiquesBlanca Sánchez-GonzálezAntonio Salar-SilvestrePublished in: Hematology (Amsterdam, Netherlands) (2021)
Our real-world data provide clinically applicable results which are in agreement with the Lugano recommendations based on trial data, highlighting the lack of utility of routine CTs in DLBCL patients achieving CMR.
Keyphrases
- clinical practice
- computed tomography
- end stage renal disease
- electronic health record
- newly diagnosed
- ejection fraction
- big data
- clinical trial
- peritoneal dialysis
- prognostic factors
- diffuse large b cell lymphoma
- study protocol
- contrast enhanced
- randomized controlled trial
- image quality
- low grade
- magnetic resonance
- machine learning
- phase iii
- positron emission tomography
- patient reported outcomes
- artificial intelligence
- placebo controlled